Home/Filings/4/0001358403-17-000030
4//SEC Filing

BELLICUM PHARMACEUTICALS, INC 4

Accession 0001358403-17-000030

CIK 0001358403operating

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:11 PM ET

Size

5.5 KB

Accession

0001358403-17-000030

Insider Transaction Report

Form 4
Period: 2017-01-30
Fair Richard A.
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2017-01-30+500,000500,000 total
    Exercise: $11.87Exp: 2027-01-29Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option vest and become exercisable on January 30, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeoperating

Related Parties

1
  • filerCIK 0001358403

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:11 PM ET
Size
5.5 KB